Health Ministry appoints 12 analysts pan India for different classes of drugs; Details
New Delhi: Through a recent Gazette notification, the Union Health Ministry has announced the appointment of Government Analysts in pan India in respect of different classes of drugs including therapeutic monoclonal antibody products, Blood Grouping Reagents, Vaccine products and others.
The Gazette dated November 26 2019, stated that the Central Government has appointed persons as government analysts for the whole of India in respect of different classes of drugs in exercise of the powers conferred by sub-section (2) of section 20 of the Drugs and Cosmetics Act, 1940 (23 of 1940) read with rule 44 of the Drugs and Cosmetics Rules, 1945.
A dozen personnel have been appointed as analysts including Scientists of Grade I, II, III- Dr Reba Chhabra, Dr Rajesh Kumar Sharma, Dr J P Prasad, Dr Meena Kumari, Madhu Erramilli, Kanchan Ahuja, Ajanta Sirkar, Dr Charu M Kamal, Gurminder Bindra, Subhash Chand, Harit Kasana, Jaipal Meena.
The class of drugs that will be analysed by the appointed analysts read- Human Immunodeficiency Virus, Hepatitis B Surface Antigen, Hepatitis C Virus, Human Immunodeficiency Virus, Hepatitis B Surface Antigen, Hepatitis C Virus, Human Albumin, Human Normal Immunoglobulin (Intramuscular and intravenous), Anti-Inhibitor Coagulation Complex, Glucose Test Strips; and Fully automated analyser based glucose reagent. Therapeutic Monoclonal Antibody Product such as Rituximab, Trastuzumab, Adalimumab, Bevacizumab have been included in the list.
The details as mentioned in the Gazette read;
| (1) | (2) | (3) |
| Serial number | Name, designation and address of the Government Analyst | Class of drugs |
| 1. | Dr. (Mrs) Reba Chhabra, Scientist Grade-I, National Institute of Biologicals, Plot No. A-32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | (i) Human Immunodeficiency Virus (ii) Hepatitis B Surface Antigen (iii) Hepatitis C Virus |
| 2. | Dr Rajesh Kumar Sharma, Scientist Grade- III, National Institute of Biologicals, Plot No. A-32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | (i) Human Immunodeficiency Virus (ii) Hepatitis B Surface Antigen (iii) Hepatitis C Virus |
| 3. | Dr. J.P. Prasad, Scientist Grade-I, National Institute of Biologicals, Plot No. A-32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | (i) Human Albumin (ii) Human Normal Immunoglobulin (Intramuscular and intravenous) (iii) Human Coagulation Factor VIII (iv) Human Coagulation Factor IX (v) Plasma Protein Fraction (vi) Fibrin Sealant Kit (vii) Anti-Inhibitor Coagulation Complex |
| 4. | Dr. Meena Kumari, Scientist Grade-II, National Institute of Biologicals, Plot No. A- 32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | (i) Human Albumin (ii) Human Normal Immunoglobulin (Intramuscular and intravenous) (iii) Human Coagulation Factor VIII (iv) Human Coagulation Factor IX (v) Plasma Protein Fraction (vi) Fibrin Sealant Kit (vii) Anti-Inhibitor Coagulation Complex |
| 5. | Ms. Madhu Erramilli, Scientist Grade-III, National Institute of Biologicals, Plot No. A- 32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | (i) Human Albumin (ii) Human Normal Immunoglobulin (Intramuscular and intravenous) (iii) Human Coagulation Factor VIII (iv) Human Coagulation Factor IX (v) Plasma Protein Fraction (vi) Fibrin Sealant Kit (vii) Anti-Inhibitor Coagulation Complex |
| 6. | Ms. Kanchan Ahuja, Scientist Grade-III, National Institute of Biologicals, Plot No. A- 32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | Blood Grouping Reagents |
| 7. | Ms. Ajanta Sirkar, Scientist Grade-II, National Institute of Biologicals, Plot No. A- 32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | (i) Glucose Test Strips; and (ii) Fully automated analyser based glucose reagent |
| 8. | Dr. Charu. M. Kamal, Scientist Grade-II, National Institute of Biologicals, Plot No. A- 32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | Recombinants Products- (i) Recombinant Insulin and Insulin analogues (ii) r-erythropoietin (EPO) (iii) r-Granulocyte Colony Stimulating Factor (G-CSF) |
| 9. | Ms. Gurminder Bindra, Scientist Grade-III, National Institute of Biologicals, Plot No. A- 32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | Recombinants Products - (i) Recombinant Insulin and Insulin analogues (ii) r-erythropoietin (EPO) (iii) r-Granulocyte Colony Stimulating Factor (G-CSF) |
| 10. | Sh. Subhash Chand, Scientist Grade-III, National Institute of Biologicals, Plot No. A- 32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | Therapeutic Monoclonal Antibody Products- (i) Rituximab (ii) Trastuzumab |
| (iii) Adalimumab (iv) Bevacizumab | ||
| 11. | Sh. Harit Kasana, Scientist Grade-II, National Institute of Biologicals, Plot No. A-32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | Vaccine Products - (i) Bacillus Calmette-Guerin (BCG) vaccine (ii) Live Attenuated Measles vaccine (iii) Live Attenuated Rubella vaccine (iv) Cell Cultutre Rabies vaccine (v) Oral Polio Vaccine |
| 12. | Sh. Jaipal Meena, Scientist Grade-III, National Institute of Biologicals, Plot No. A- 32, Sector – 62, Institutional Area, Noida, Uttar Pradesh – 201309. | Vaccine Products - (i) Bacillus Calmette-Guerin (BCG) vaccine (ii) Live Attenuated Measles vaccine (iii) Live Attenuated Rubella vaccine (iv) Cell Cultutre Rabies vaccine (v) Oral Polio Vaccine |
Also Read: Pharmacists to protest at Jantar Mantar against the amendment of Schedule K of Drugs and Cosmetics Act
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd